Sumaya N. Almohareb

2.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Sumaya N. Almohareb is a scholar working on Pharmacology, Epidemiology and Surgery. According to data from OpenAlex, Sumaya N. Almohareb has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Sumaya N. Almohareb's work include Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Antibiotic Use and Resistance (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Sumaya N. Almohareb is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Antibiotic Use and Resistance (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Sumaya N. Almohareb collaborates with scholars based in Saudi Arabia and United States. Sumaya N. Almohareb's co-authors include Nada Alsuhebany, Majed S. Al Yami, Atheer Aldairem, Shuroug A. Alowais, Khalid Bin Saleh, Hisham A. Badreldin, Tariq Alqahtani, Mohammed Alrashed, Abdulrahman Alshaya and Sahar S. Alghamdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Vaccine.

In The Last Decade

Sumaya N. Almohareb

8 papers receiving 1.2k citations

Hit Papers

Revolutionizing healthcare: the role of artificial intell... 2023 2026 2024 2025 2023 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revolutionizing healthcare: the role of artificial intelligence in clinical practice
    2023 1.2k citations Shuroug A. Alowais, Sahar S. Alghamdi et al. BMC Medical Education profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumaya N. Almohareb Saudi Arabia 4 617 294 271 173 137 15 1.3k
Atheer Aldairem Saudi Arabia 3 617 1.0× 294 1.0× 271 1.0× 173 1.0× 137 1.0× 6 1.2k
Nada Alsuhebany Saudi Arabia 7 618 1.0× 297 1.0× 283 1.0× 173 1.0× 153 1.1× 25 1.4k
Shuroug A. Alowais Saudi Arabia 6 685 1.1× 367 1.2× 284 1.0× 177 1.0× 149 1.1× 23 1.5k
Mohammed Alrashed Saudi Arabia 4 686 1.1× 368 1.3× 287 1.1× 176 1.0× 150 1.1× 21 1.5k
Khalid Bin Saleh Saudi Arabia 9 685 1.1× 369 1.3× 284 1.0× 176 1.0× 168 1.2× 29 1.6k
Shmeylan Al Harbi Saudi Arabia 11 617 1.0× 296 1.0× 297 1.1× 176 1.0× 157 1.1× 25 1.5k
Abdulrahman Alshaya Saudi Arabia 9 686 1.1× 368 1.3× 285 1.1× 178 1.0× 167 1.2× 31 1.6k
Tariq Alqahtani Saudi Arabia 8 686 1.1× 368 1.3× 286 1.1× 176 1.0× 145 1.1× 30 1.6k
Jiming Xu China 5 674 1.1× 418 1.4× 416 1.5× 177 1.0× 138 1.0× 13 1.3k
Majed S. Al Yami Saudi Arabia 12 687 1.1× 367 1.2× 286 1.1× 176 1.0× 151 1.1× 53 1.8k

Countries citing papers authored by Sumaya N. Almohareb

Since Specialization
Citations

This map shows the geographic impact of Sumaya N. Almohareb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumaya N. Almohareb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumaya N. Almohareb more than expected).

Fields of papers citing papers by Sumaya N. Almohareb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumaya N. Almohareb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumaya N. Almohareb. The network helps show where Sumaya N. Almohareb may publish in the future.

Co-authorship network of co-authors of Sumaya N. Almohareb

This figure shows the co-authorship network connecting the top 25 collaborators of Sumaya N. Almohareb. A scholar is included among the top collaborators of Sumaya N. Almohareb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumaya N. Almohareb. Sumaya N. Almohareb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Alowais, Shuroug A., Atheer Aldairem, Sumaya N. Almohareb, et al.. (2025). Characteristics and Outcomes of Patients Treated with Carbapenem Versus Non-carbapenem Therapy for AmpC-Producing Enterobacterales Bacteremia: A Retrospective Study. Infectious Diseases and Therapy. 14(5). 1061–1074.
2.
Almohareb, Sumaya N., et al.. (2025). Clopidogrel Use in Saudi Arabia: Prescription Patterns and Prevalence of Common Concurrent Medications. SHILAP Revista de lepidopterología. 5(2). 92–99. 1 indexed citations
3.
Alsuhebany, Nada, et al.. (2025). Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units. Frontiers in Cardiovascular Medicine. 12. 1573080–1573080.
4.
Yami, Majed S. Al, et al.. (2025). Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study. Clinical and Applied Thrombosis/Hemostasis. 31. 3005494559–3005494559.
5.
6.
Almohareb, Sumaya N., et al.. (2025). Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis. Expert Opinion on Drug Safety. 1–9. 3 indexed citations
7.
Almohareb, Sumaya N., et al.. (2024). Effectiveness of oral antibiotics in managing extended-spectrum B-lactamase urinary tract infections: A retrospective analysis. SAGE Open Medicine. 12. 3932110809–3932110809. 2 indexed citations
8.
Almohareb, Sumaya N., Osamah M. Alfayez, Mohammed Kanan Alshammari, et al.. (2024). Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes. Journal of Clinical Medicine. 13(21). 6532–6532. 6 indexed citations
9.
Almohareb, Sumaya N., et al.. (2024). Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020. Therapeutic Advances in Drug Safety. 15. 1591725046–1591725046. 1 indexed citations
10.
Almohareb, Sumaya N., et al.. (2024). Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study. Drugs - Real World Outcomes. 11(2). 331–339.
11.
Alowais, Shuroug A., Sahar S. Alghamdi, Nada Alsuhebany, et al.. (2023). Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Medical Education. 23(1). 689–689. 1238 indexed citations breakdown →
12.
Alsuhebany, Nada, et al.. (2023). Identifying gaps in vaccination perception after mandating the COVID-19 vaccine in Saudi Arabia. Vaccine. 41(24). 3611–3616. 6 indexed citations
13.
Badreldin, Hisham A., Khalid Bin Saleh, Abdullah A. Alhifany, et al.. (2022). Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional Study. International Journal of Environmental Research and Public Health. 19(13). 8014–8014.
14.
Alowais, Shuroug A., et al.. (2022). Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: A nationwide cross-sectional study. Saudi Pharmaceutical Journal. 31(2). 222–227. 1 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atheer Aldairem Breakdown of academic impact, for papers by Nada Alsuhebany Breakdown of academic impact, for papers by Shuroug A. Alowais Breakdown of academic impact, for papers by Mohammed Alrashed Breakdown of academic impact, for papers by Khalid Bin Saleh Breakdown of academic impact, for papers by Shmeylan Al Harbi Breakdown of academic impact, for papers by Abdulrahman Alshaya Breakdown of academic impact, for papers by Tariq Alqahtani Breakdown of academic impact, for papers by Jiming Xu Breakdown of academic impact, for papers by Majed S. Al Yami
Rankless by CCL
2026